SYMBIO PHARMACEUTICALS LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 4582 for the last quarter is 1.17 B JPY, and it's 5.94% lower compared to the previous quarter. The net income of Q4 23 is -1.17 B JPY.